Recent Material Events - Nanogen, Inc (NGEN)

Filing Date	Description
2008-08-15	On August 14, 2008, Nanogen, Inc. (“Nanogen” or the “Company”) entered into a share exchange agreement (the “Share Exchange Agreement”) with Financiére Elitech S.A.S. (“Elitech”), an independent distribu ...
2008-08-13	On August 13, 2008, Nanogen, Inc. issued a press release to report its financial results for the quarter ended June 30, 2008. The release is furnished as Exhibit 99.1 hereto. ...
2008-08-05	On July 31, 2008, the Audit Committee of the Board of Directors of Nanogen, Inc. (the “Company”) determined that the Company should restate its previously issued condensed consolidated financial statement for the quarter ended March 31, 200 ...
2008-07-01	Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-06-05	99.1 Press Release dated June 5, 2008. Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-05-23	Prior to May 27, 2008, the Company submitted a transfer application with NASDAQ to transfer listing of its common stock to the NASDAQ Capital Market. On May 22, 2008, NASDAQ approved the transfer application, and the Company expects to be afforded an ...
2008-05-23	The Company’s qualitative cardiac products, acquired two years ago from Spectral Diagnostics, are currently manufactured in Toronto while development and pilot manufacturing activities for the Company’s next generation immunoassay activitie ...
2008-03-31	Under the terms of the Assignment Agreement, DRLP2 is entitled to receive all royalties generated under the License Agreement from and after January 1, 2012. Epoch has also designated DRLP2 as its agent to inspect records of ABI relating to the royal ...
2008-03-28	As previously disclosed on a Form 8-K filed by Nanogen, Inc. (the “Company”) on March 14, 2008 (the “March 14, 2008 Form 8-K”), the Company entered into an Amendment and Exchange Agreement, dated March 13, 2008 (the “Exchange ...
2008-03-14	The Old Notes were issued in the Company’s debt financing transaction (the “August 2007 Debt Financing”) pursuant to the Indenture, dated August 27, 2008, between the Company and The Bank of New York Trust Company, N.A. as trustee (the ...